Patents
Patents for C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
03/2005
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/03/2005WO2005019181A1 Migrastatin analog cell migration inhibitors
03/03/2005WO2005018545A2 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
03/03/2005CA2535337A1 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
02/2005
02/17/2005WO2004080391A3 Novel antibacterial agents
02/15/2005US6855705 Non-polyene and ansa macrolide antibiotics such as 11-O-methyl -17-(1-azetidinyl)-17-demethoxygeldanamycin, used as antiproliferative or anticarcinogenic agents
02/10/2005WO2003050295A3 Assays and implements for determining and modulating hsp90 binding activity
02/08/2005US6852713 Lactam derivatives and methods of their use
02/02/2005EP1297175A4 Methods and compounds for modulating nuclear receptor coactivator binding
02/02/2005CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
02/01/2005US6849597 Administering a growth hormone secretagogue to a mammal, for preventing nerve cells degeneration or death of neurons
01/2005
01/27/2005WO2005007618A1 Method for production of $g(a),$g(b)-unsaturated amide compounds
01/27/2005CA2531603A1 Method for production of .alpha., .beta.-unsaturated amide compounds
01/12/2005EP1165532B1 Antibacterial agents
01/12/2005CN1562975A Method for preparing 1-methyl-3-ethyl-3-(3-hydroxy phenyl)-hexa hydrogen-1 H azepin hydrochloride
01/05/2005EP1493738A1 Epothilone derivatives
12/2004
12/29/2004EP1435939A4 Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
12/29/2004CN1558757A Process for preparing 17-allyl amino geldanamycin (17-AAG) and other ansamycins
12/23/2004US20040259876 Bicyclic compound, production and use thereof
12/22/2004EP1489106A1 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same
12/08/2004EP1484322A1 Process for producing optically active sulfoxide derivative
12/08/2004EP1483395A1 Process to prepare and isolate geldanamycin
12/08/2004CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/02/2004US20040242553 Drugs to improve synaptic transmission
11/2004
11/18/2004WO2004034970A3 Macrocyclic lactams
11/16/2004US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/11/2004US20040224936 Macrocyclic compounds useful as pharmaceuticals
11/04/2004WO2004093796A2 Lactam derivatives and methods of their use
11/04/2004WO2004087673A3 Migrastatin analogs and uses thereof
11/03/2004EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004CN1543452A 1,4-disubstituted benzenes as insecticides
10/2004
10/28/2004WO2004082357A3 Novel method for the synthesis of derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid and application thereof to the synthesis of perindopril
10/21/2004US20040209857 Pharmaceutical compositions containing the compounds and methods for their use are also disclosed. Binding opioid receptors to treat a condition or disease selected from the group consisting of: gastrointestinal dysfunction, ileus,
10/20/2004EP1468990A1 Piperazine derivative
10/20/2004EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/14/2004WO2004087673A2 Migrastatin analogs and uses thereof
10/14/2004WO2004087672A1 Migrastatin analog compositions and uses thereof
10/14/2004US20040204395 Water-soluble drugs and methods for their production
10/14/2004CA2520377A1 Migrastatin analog compositions and uses thereof
10/07/2004WO2004084809A2 Neuroprotective macrocylic compounds and methods for their use
09/2004
09/30/2004WO2004083237A1 Novel method for the synthesis of (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof and application to the synthesis of perindopril
09/30/2004WO2004082357A2 Novel method for the synthesis of derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid and application thereof to the synthesis of perindopril
09/23/2004WO2004080391A2 Novel antibacterial agents
09/23/2004CA2801100A1 Novel antibacterial agents
09/15/2004EP1322325A4 Inhibiting hepatitis c virus processing and replication
08/2004
08/11/2004CN1519233A 12-(imino ether)-1, 15-pentadelactam, as well as preparation method and its application in bactericide
08/04/2004CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
08/03/2004US6770668 Pharmaceutically active compounds and methods of use
07/2004
07/28/2004CN1515563A Aryl substituted piperazine for curing benign prostatauxe
07/28/2004CN1515556A Intermediate compound for preparing aryl substituted piperazine
07/20/2004US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
07/14/2004EP1435939A2 Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
07/14/2004EP0983248B1 Analogs of duocarmycin and cc-1065
07/14/2004CN1157189C Semi-synthetic ecteinascidins
07/08/2004US20040132997 Macrocyclic lactams
07/01/2004WO2004054624A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
07/01/2004CA2549463A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
06/2004
06/30/2004EP0945436B1 Cytotrienins, process for preparing the same, and antitumor agent
06/29/2004US6756500 Subjecting substituted alpha, omega-diene in presence of ruthenium, osmium or molybdenum homogeneous or heterogeneous catalyst to metathesis reaction in presence of ionic liquid to form cyclic compound
06/24/2004US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide
06/23/2004EP1429783A2 Multi-use multimodal imaging chelates
06/22/2004US6753429 1,4-disubstituted benzenes as insecticides
06/17/2004WO2004050623A1 Methods for preparing phenylalkyne derivatives
06/17/2004CA2507875A1 Methods for preparing phenylalkyne derivatives
06/10/2004WO2003066005A3 Ansamycins having improved pharmacological and biological properties
06/08/2004US6747055 Water-soluble drugs and methods for their production
06/03/2004US20040106788 asymmetric hydrogenation of a lactam-enamide; multi-step synthesis
06/03/2004US20040106593 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
06/02/2004EP1423376A1 Bicyclic compound, production and use thereof
05/2004
05/26/2004EP1420747A2 Benzoquinone ansamycins
05/12/2004CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia
05/06/2004US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists
04/2004
04/29/2004WO2004034970A2 Macrocyclic lactams
04/22/2004US20040077058 Domains of geldanamycin and herbimycin polyketide synthases, polynucleotides that encode such enzymes, and to host cells in which such encoding polynucleotides can be advantageously expressed
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/2004
03/25/2004US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics
03/24/2004CN1484639A Geldanamycin derivative and method of treating cancer same
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/23/2004US6710073 Drugs that induce long term potentiation (ltp) and enhance cognitive function in mammals
03/18/2004WO2003106653A3 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof
03/18/2004US20040053909 Administering to a cancer patient a geldanamycin derivative containing dimethylaminoethylamine (at 17the position) group attached to the ring, for the treatment of cancer
03/16/2004CA2096460C Dual action inhibitors
03/04/2004WO2003013430A3 Benzoquinone ansamycins
03/02/2004US6699988 By reacting phosgene and lactam in the presence of a non-nucleophilic aliphatic tertiary amine, such as n,n-diisopropylethylamine; high purity, good yields
03/02/2004US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims
02/2004
02/25/2004EP1073629B1 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
02/24/2004US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
02/24/2004US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example
02/19/2004US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
02/18/2004EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
02/03/2004US6686477 Multistep chemical synthesis, including asymmetric hydrogenation of a lactam-enamide to produce an intermediate that can be used to make unspecified pharmaceuticals
01/2004
01/27/2004US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/20/2004US6680314 Azacyclooctane and heptane derivatives, their preparation and use in therapy
01/13/2004US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents
01/13/2004US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis
01/13/2004US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
01/13/2004US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/02/2004EP1373215A1 Geldanamycin derivative and method of treating cancer using same
01/02/2004EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17